COVID-19 inflammation and implications in drug delivery

Growing evidence indicates that hyperinflammatory syndrome and cytokine storm observed in COVID-19 severe cases are narrowly associated with the disease’s poor prognosis. Therefore, targeting the inflammatory pathways seems to be a rational therapeutic strategy against COVID-19. Many anti-inflammato...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of controlled release 2022-06, Vol.346, p.260-274
Hauptverfasser:	Zoulikha, Makhloufi, Huang, Feifei, Wu, Zhenfeng, He, Wei
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Inflammatory Agents - therapeutic use Biomimetics Bioresponsive COVID-19 Drug Treatment Drug delivery Drug Delivery Systems Humans Inflammation Inflammation - drug therapy Mesenchymal stem cells Nanodecoys Nanomedicine SARS-CoV-2 Tissue Distribution
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!